Clinical & Experimental Metastasis

Papers
(The H4-Index of Clinical & Experimental Metastasis is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis96
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG70
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics53
Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®)47
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria37
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models36
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches35
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma29
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption21
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics20
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression20
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection19
Oncolytic intralesional therapy for metastatic melanoma17
Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials17
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss17
Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review17
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage 16
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions16
Cell blebbing novel therapeutic possibilities to counter metastasis16
0.049293994903564